Why glutathione is the antioxidant worth caring about

If you spend any time reading about healthy ageing, detoxification, immunity or cellular resilience, one molecule keeps surfacing: glutathione. It’s a small tripeptide (built from glutamic acid, cysteine and glycine) present in every cell of the human body, and it is widely described in the scientific literature as the body’s master antioxidant. (Labarrere & Kassab, 2022)

Glutathione earns that title for three reasons:
• It directly neutralises reactive oxygen species (ROS) — the unstable molecules generated by normal metabolism, exercise, environmental toxins, and inflammation.
• It regenerates other antioxidants, including vitamin C and vitamin E, so they can keep working.
• It is central to liver detoxification and to the binding and removal of heavy metals.

The catch is that glutathione (specifically its reduced, active form, GSH) tends to decline with age, with chronic illness, and under sustained oxidative stress. (Iskusnykh et al., 2022) Keeping the GSH pool topped up — and the ratio of reduced to oxidised glutathione (GSH/GSSG) healthy — is one of the more biologically meaningful goals you can aim for.

So a sensible question is: does cannabidiol (CBD) influence this system?

The short answer, based on the preclinical literature, is: yes — and probably in more ways than one.

CBD as a direct antioxidant — the founding observation

The story begins in 1998, when Hampson and colleagues at the U.S. National Institutes of Health published a landmark paper in Proceedings of the National Academy of Sciences showing that both CBD and THC behave as direct antioxidants in cortical neuron cultures, and that this activity is not dependent on cannabinoid receptors. In their cyclic-voltammetry experiments, CBD was more potent at protecting neurons from glutamate-induced oxidative damage than either ascorbate (vitamin C) or α-tocopherol (vitamin E). (Hampson, Grimaldi, Axelrod, & Wink, 1998)

That single finding is the seed of much of what followed: CBD can directly mop up free radicals. Direct radical scavenging is only part of the picture, and arguably the less interesting part.

The deeper mechanism: CBD and the Nrf2 pathway

Most of your antioxidant defence is actually produced by your own cells, on demand. The control switch is a transcription factor called Nrf2 (nuclear factor erythroid 2-related factor 2). When Nrf2 is activated, it travels into the cell nucleus and turns on a long list of cytoprotective genes — including the genes responsible for glutathione synthesis, glutathione peroxidase (GPx), superoxide dismutase (SOD), and heme oxygenase-1 (HO-1).

A growing body of work — recently summarised in thorough reviews — shows that CBD is an effective modulator of the Nrf2/Keap1 axis. (Atalay Ekiner, Gęgotek, & Skrzydlewska, 2022; Pereira, Hackett, O’Driscoll, Sun, & Downer, 2021) The practical consequence: CBD doesn’t just neutralise individual free radicals; it appears to upregulate the cellular machinery that produces glutathione and its companion enzymes in the first place.

Several preclinical studies have measured this directly:

• In rats with monocrotaline-induced pulmonary hypertension, CBD increased total antioxidant capacity, raised GSH concentrations, and elevated glutathione reductase (GSR) activity in lung tissue. (Sadowska et al., 2022)
• In a mouse model of global hypoxia, animals pretreated with CBD maintained higher GSH levels than untreated controls, and showed reduced lipid-peroxidation markers (MDA, 8-epi-PGF2α). (Khaksar et al., 2024)
• In rats with skin exposed to UV radiation, topical CBD raised GSH, thioredoxin (Trx), and the activities of Cu,Zn-SOD, GPx and TrxR in the affected tissue. (Jastrząb et al., 2021)
• In a model of diabetic cardiomyopathy, CBD attenuated oxidative stress, fibrosis and cardiac dysfunction, and reduced markers of lipid peroxidation in the heart. (Rajesh et al., 2010)

In short: across multiple tissues and stressors, CBD appears to support the glutathione system — and to do so largely by influencing the transcriptional programme that controls antioxidant production.

What about humans?

The mechanistic and preclinical evidence is genuinely encouraging, but human clinical trials specifically measuring glutathione status before and after CBD supplementation are still scarce. Most reviews of CBD’s antioxidant pharmacology explicitly note this gap. (Atalay, Jarocka-Karpowicz, & Skrzydlewska, 2020; Pereira, Hackett, O’Driscoll, Sun, & Downer, 2021)

Two practical reasons that gap is worth flagging:

1. Dose, formulation and tissue context shape the result. Several reviews note that CBD’s effects on redox balance can be biphasic — antioxidant at one dose, pro-oxidant at much higher doses, or in cancer-cell models specifically. (Pereira, Hackett, O’Driscoll, Sun, & Downer, 2021) This is common for plant-derived bioactives; it simply means “more is better” is the wrong heuristic.
2. Bioavailability and entourage effects. Full-spectrum hemp extracts also contain flavonoids (quercetin, apigenin, rutin) and terpenes (myrcene, β-caryophyllene, limonene, pinene, linalool), several of which have their own documented antioxidant activity. Whether the GSH-supportive signal seen for isolated CBD is enhanced when delivered as a full-spectrum extract is plausible based on what we know about the entourage effect, but it has not yet been quantified in well-controlled human trials.
   So: the direction of the evidence is consistent and biologically coherent. The magnitude of the effect in healthy humans, the optimal dose, and the relative contribution of CBD versus the wider hemp matrix are still open questions.

A pragmatic takeaway

If you are someone who already cares about glutathione — perhaps you’ve explored NAC (N-acetyl cysteine), liposomal GSH, or sulphur-rich foods like cruciferous vegetables, eggs and whey — then the evidence that CBD plausibly recruits the same upstream switch (Nrf2) that drives endogenous glutathione production is worth knowing.

It does not mean CBD is a glutathione substitute. It means CBD may belong in the same conceptual category: a tool that helps the body’s own antioxidant defence system stay switched on. That idea is consistent with how the endocannabinoid system is increasingly understood — as a homeostatic regulator that nudges multiple stress-response pathways back toward balance.

For Hemp for Humanity, this is exactly the kind of intersection we want to keep watching: a well-supported preclinical signal, a coherent mechanism, and a clear need for human studies. We will be adding the most relevant of the papers cited here to our Research page so readers can dig into the primary literature themselves.

If you’ve been exploring antioxidant strategies and haven’t yet considered cannabinoids alongside them, it may be time to take another look — and to support the research that turns “promising signal” into “clinical certainty.”

Read the studies on our research page: hempforhumanity.eu/research

Key references

• Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. PNAS, 95(14), 8268–8273.
• Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2020). Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, 9(1), 21.
• Atalay Ekiner, S., Gęgotek, A., & Skrzydlewska, E. (2022). The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress. Redox Biology, 57, 102489.
• Pereira, S. R., Hackett, B., O’Driscoll, D. N., Sun, M. C., & Downer, E. J. (2021). Cannabidiol modulation of oxidative stress and signalling. Neuronal Signaling, 5(3), NS20200080.
• Sadowska, O., et al. (2022). Cannabidiol improves antioxidant capacity and reduces inflammation in the lungs of rats with monocrotaline-induced pulmonary hypertension. Molecules, 27(10), 3327.
• Khaksar, S., et al. (2024). Cannabidiol effectively prevents oxidative stress and stabilizes HIF-1α in an animal model of global hypoxia. Scientific Reports, 14, 16923.
• Jastrząb, A., Gęgotek, A., & Skrzydlewska, E. (2021). Antioxidant and anti-inflammatory effect of cannabidiol contributes to the decreased lipid peroxidation of keratinocytes of rat skin exposed to UV radiation. Oxidative Medicine and Cellular Longevity, 2021, 6647222.
• Rajesh, M., et al. (2010). Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. JACC, 56(25), 2115–2125.
• Labarrere, C. A., & Kassab, G. S. (2022). Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation. Frontiers in Nutrition, 9, 1007816.
• Iskusnykh, I. Y., Zakharova, A. A., & Pathak, D. (2022). Glutathione in brain disorders and aging. Molecules, 27(1), 324.

This article is for educational purposes and does not constitute medical advice.

Follow Hemp for Humanity on Telegram: https://t.me/hempforhumanityofficial